Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q4 2021 call → NOWe need to determine if management's forward account is substantially about counterparties' own growth/expansion, with the company already inside that growth, and that growth being early and large relative to the company. Let's analyze the transcript. Management (Mike Slessor and Shai Shahar) discusses various segments: Foundry and Logic, DRAM, Flash, Systems. They talk about demand drivers, capacity expansions, supply chain issues, etc. Key points: - They mention "foundry strength" driven by "release of new designs on existing nodes" and "high performance compute applications." They talk about customers investing in leading edge capacity, advanced packaging architectures like EMIB, Foveros, 3DFabric. They say these drive test intensity and complexity, creating tailwinds for probe card demand. - They mention "customers continued to release and ramp multiple new designs in volume" for DRAM. - They mention "adoption of FRT optical metrology tools and advanced packaging applications" and "customer investments in engineering progress to enable industry innovation in new CMOS architectures like gate-all-around and optical applications like Silicon Photonics." - They mention a new program for cryogenic test tools as a service for quantum computing developers. But do they narrate specific counterparties' own trajectories? They talk about "customers" generally, not specific named or unmistakably described parties. They mention "our largest customer" in a question from analyst, but management doesn't elaborate on that customer's specific plans. They talk about "foundry and logic" demand driven by new designs, but that's more about market trends than specific counterparties' scaling. They also discuss their own capacity expansion (Livermore) and supply chain issues. The forward outlook is based on seasonal decline and constraints.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.